biopharmaceutical
Sanofi Announces $2.9 Billion Acquisition of BioPharma Diabetes Drug Maker
Paris-based Sanofi S.A. announced a definitive agreement to pay $2.9 billion for diabetes drug manufacturer Provention Bio, Inc., a U.S.-based, biopharmaceutical company focused on intercepting…